A retrospective cohort study of <29-week-gestation infants with evolving BPD defined at age 28 days within the Pediatric Health Information System database. Controlling for observed confounding with ...

TORONTO, ON — Two commonly used drugs used in the treatment of chronic obstructive pulmonary disease (COPD) are associated with an increased risk of cardiovascular events, a new review concludes [1].

Objectives: To determine the effect of prophylactic treatment with an inhaled bronchodilator and anti-inflammatory on arterial saturation (Sao 2) in trained non-asthmatic male athletes with exercise ...

A new study reveals several new gene variants that are associated with how people living with chronic obstructive pulmonary disease respond to inhaled bronchodilators. A new study from Brigham and ...

Please provide your email address to receive an email when new articles are posted on . Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or ...

(Reuters Health) - People with chronic obstructive pulmonary disease (COPD) who use long-acting inhaled bronchodilators may have an increased risk of heart attacks and strokes right after they start ...

Identifying DNA variants associated with bronchodilator responsiveness may reveal genetic pathways associated with the pathogenesis of chronic obstructive pulmonary disease and may identify novel ...

Delivery of asthma medication with pressurized metered-dose inhalers is economical, effective, and convenient. This method of delivery is a critical part of the medical management program for most ...

NEW YORK (Reuters Health) - Infants born prematurely at very low birth weights who are treated with inhaled nitric oxide in the neonatal intensive care unit are significantly less likely to need ...

The results show the importance of diagnosing lung conditions through spirometry as well the necessity for more effective therapies for patients without COPD. Dual bronchodilators, often prescribed ...